• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Endra Life Sciences Inc (NQ: NDRA )

    5.920 +5.700 (+2590.91%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Endra Life Sciences Inc

    < Previous 1 2 3 4 5 6 7 8 Next >
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
    From ENDRA Life Sciences Inc.
    Via Business Wire
    ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023
    From ENDRA Life Sciences Inc.
    Via Business Wire
    ENDRA Life Sciences: Q2 Earnings Insights
      ENDRA Life Sciences (NASDAQ:NDRA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
    From ENDRA Life Sciences Inc.
    Via Business Wire
    ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
    From ENDRA Life Sciences Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 79 companies reached new 52-week lows. 
    Via Benzinga
    ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
    From ENDRA Life Sciences Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Friday
      On Friday, 64 companies achieved new lows for the year. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers 
    Via Benzinga
    ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
    From ENDRA Life Sciences Inc.
    Via Business Wire
    Earnings Scheduled For November 14, 2022
    Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
    Via Benzinga
    Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
    Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also... 
    Via Benzinga
    ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
    From ENDRA Life Sciences Inc.
    Via Business Wire
    ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
    From ENDRA Life Sciences Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion. 
    Via Benzinga
    ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences
    From ENDRA Life Sciences Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
      
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
      
    Via Benzinga
    ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System
    From ENDRA Life Sciences Inc.
    Via Business Wire
    ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
    From ENDRA Life Sciences Inc.
    Via Business Wire
    Preview: ENDRA Life Sciences Earnings
      ENDRA Life Sciences (NASDAQ:NDRA) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. 
    Via Benzinga
    ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022
    From ENDRA Life Sciences Inc.
    Via Business Wire
    Earnings Scheduled For August 15, 2022
    Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
    Via Benzinga
    ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices
    From ENDRA Life Sciences Inc.
    Via Business Wire
    ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
    From ENDRA Life Sciences Inc.
    Via Business Wire
    ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System
    From ENDRA Life Sciences
    Via Business Wire
    InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
    Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
    Via Benzinga
    Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.